Alarmingly high segregation frequencies of quinolone resistance alleles within human and animal microbiomes are not explained by direct clinical antibiotic exposure

Genome Biology and Evolution

Volumn 7, Issue 6, 2015, Pages 1743-1757

  Field, Wesley ^a   Hershberg, Ruth ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Allele frequencies; Antibiotic resistance; Metagenomics; Microbiome

Indexed keywords

ANTIINFECTIVE AGENT; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; QUINOLONE DERIVATIVE; RIFAMYCIN; STREPTOMYCIN;

ANIMAL; ANTIBIOTIC RESISTANCE; BACTERIUM; CLASSIFICATION; FEMALE; GASTROINTESTINAL TRACT; GENE FREQUENCY; GENETICS; HUMAN; INFANT; MICROBIOLOGY; MICROFLORA;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; DNA GYRASE; DNA TOPOISOMERASE IV; DRUG RESISTANCE, BACTERIAL; FEMALE; GASTROINTESTINAL TRACT; GENE FREQUENCY; HUMANS; INFANT; MICROBIOTA; QUINOLONES; RIFAMYCINS; STREPTOMYCIN;

EID: 84979849749     PISSN: None     EISSN: 17596653     Source Type: Journal    
DOI: 10.1093/gbe/evv102     Document Type: Article

References (58)

1. Allen HK, et al. 2010. Call of the wild: antibiotic resistance genes in natural environments. Nat Rev Microbiol. 8:251-259.
2. Andersson DI, Hughes D. 2010. Antibiotic resistance and its cost: is it possible to reverse resistance? Nat Rev Microbiol. 8:260-271.
3. Angst DC, Hall AR. 2013. The cost of antibiotic resistance depends on evolutionary history in Escherichia coli. BMC Evol Biol. 13:163.
4. Bagel S, Hullen V,Wiedemann B, Heisig P. 1999. Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli. Antimicrob Agents Chemother. 43:868-875.
5. Bahrmand AR, Titov LP, Tasbiti AH, Yari S, Graviss EA. 2009. High-Level Rifampin Resistance Correlates with Multiple Mutations in the rpoB Gene of Pulmonary Tuberculosis Isolates from the Afghanistan Border of Iran. J Clin Microbiol. 47:2744-2750.
6. Ballif M, et al. 2012. Drug resistance-conferring mutations in Mycobacterium tuberculosis from Madang, Papua New Guinea. BMC Microbiol. 12: 191.
7. Barrick JE, Kauth MR, Strelioff CC, Lenski RE. 2010. Escherichia coli rpoB mutants have increased evolvability in proportion to their fitness defects. Mol Biol Evol. 27:1338-1347.
8. Bjedov I, et al. 2003. Stress-induced mutagenesis in bacteria. Science 300:1404-1409.
9. Boulund F, Johnning A, Pereira MB, Larsson DG, Kristiansson E. 2012. A novel method to discover fluoroquinolone antibiotic resistance (qnr) genes in fragmented nucleotide sequences. BMC Genomics 13:695.
10. Bruen TC, Philippe H, Bryant D. 2006. A simple and robust statistical test for detecting the presence of recombination. Genetics 172:2665-2681.
11. Carr JF, Hamburg DM, Gregory ST, Limbach PA, Dahlberg AE 2006. Effects of streptomycin resistance mutations on posttranslational modification of ribosomal protein S12. J Bacteriol. 188:2020-2023.
12. Cavusoglu C, Hilmioglu S, Guneri S, Bilgic A. 2002. Characterization of rpoB mutations in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Turkey by DNA sequencing and line probe assay. J Clin Microbiol. 40:4435-4438.
13. Conrad S, et al. 1996. gyrA mutations in high-level fluoroquinolone-resistant clinical isolates of Escherichia coli. J Antimicrob Chemother. 38:443-455.
14. de la Campa AG, et al. 2004. Fluoroquinolone resistance in penicillinresistant Streptococcus pneumoniae clones, Spain. Emerg Infect Dis. 10:1751-1759.
15. de Vries LE, et al. 2011. The gut as reservoir of antibiotic resistance: microbial diversity of tetracycline resistance in mother and infant. PLoS One 6:e21644.
16. Eaves DJ, Liebana E,WoodwardMJ, Piddock LJV. 2002. Detection of gyrA mutations in quinolone-resistant Salmonella enterica by denaturing high-performance liquid chromatography. J Clin Microbiol. 40:4121-4125.
17. Ferrandiz MJ, Fenoll A, Linares J, De La Campa AG. 2000. Horizontal transfer of parC and gyrA in fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother. 44:840-847.
18. Gilliver MA, Bennett M, Begon M, Hazel SM, Hart CA. 1999. Enterobacteria - antibiotic resistance found in wild rodents. Nature 401:233-234.
19. Godoy-Vitorino F, et al. 2008. Bacterial community in the crop of the hoatzin, a neotropical folivorous flying bird. Appl Environ Microbiol. 74:5905-5912.
20. Hu YF, et al. 2013. Metagenome-wide analysis of antibiotic resistance genes in a large cohort of human gut microbiota. Nat Commun. 4: 2151.
21. Ishiguro F, et al. 2006. [Mutations of gyrA gene and parC gene in fluoroquinolone-resistant Escherichia coli isolates from sporadic diarrheal cases]. Kansenshogaku Zasshi 80:507-512.
22. Janoir C, Zeller V, Kitzis MD, Moreau NJ, Gutmann L. 1996. High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrA. Antimicrob Agents Chemother. 40:2760-2764.
23. Kaneko A, et al. 2000. Comparison of gyrA and parC mutations and resistance levels among fluoroquinolone-resistant isolates and laboratory-derived mutants of oral streptococci. J Antimicrob Chemother. 45:771-775.
24. Katz S, Hershberg R. 2013. Elevated mutagenesis does not explain the increased frequency of antibiotic resistant mutants in starved aging colonies. PLoS Genet. 9:e1003968.
25. Kehrenberg C, Cloeckaert A, Klein G, Schwarz S. 2009. Decreased fluoroquinolone susceptibility in mutants of Salmonella serovars other than Typhimurium: detection of novel mutations involved in modulated expression of ramA and soxS. J Antimicrob Chemother. 64:1175-1180.
26. Kunz AN, et al. 2012. Impact of fluoroquinolone resistance mutations on gonococcal fitness and in vivo selection for compensatory mutations. J Infect Dis. 205:1821-1829.
27. Makadia JS, Jain A, Patra SK, Sherwal BL, Khanna A. 2012. Emerging trend of mutation profile of rpoB gene in MDR tuberculosis, North India. Indian J Clin Biochem. 27:370-374.
28. Mariam DH, Mengistu Y, Hoffner SE, Andersson DI. 2004. Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis. Antimicrob Agents Chemother. 48:1289-1294.
29. Markowitz VM, et al. 2008. IMG/M: a data management and analysis system for metagenomes. Nucleic Acids Res. 36:D534-D538.
30. Markowitz VM, et al. 2012. IMG: the Integrated Microbial Genomes database and comparative analysis system. Nucleic Acids Res. 40:D115-D122.
31. Martinez JL. 2008. Antibiotics and antibiotic resistance genes in natural environments. Science 321:365-367.
32. Martinez JL, Coque TM, Baquero F. 2015. What is a resistance gene? Ranking risk in resistomes. Nat Rev Microbiol. 13:116-123.
33. Miskinyte M, Gordo I. 2013. Increased survival of antibiotic-resistant Escherichia coli inside macrophages. Antimicrob Agents Chemother. 57:189-195.
34. Mokrousov I, Otten T, Vyshnevskiy B, Narvskaya O. 2003. Allele-specific rpoB PCR assays for detection of rifampin-resistant Mycobacterium tuberculosis in sputum smears. Antimicrob Agents Chemother. 47:2231-2235.
35. Oh H, El Amin N, Davies T, Appelbaum PC, Edlund C. 2001. gyrA mutations associated with quinolone resistance in Bacteroides fragilis group strains. Antimicrob Agents Chemother. 45:1977-1981.
36. Okamoto-Hosoya Y, Okamoto S, Ochi K. 2003. Development of antibiotic-overproducing strains by site-directed mutagenesis of the rpsL gene in Streptomyces lividans. Appl Environ Microbiol. 69:4256-4259.
37. Osterblad M, Norrdahl K, Korpimaki E, Huovinen P. 2001. Antibiotic resistance - how wild are wild mammals? Nature 409:37-38.
38. Paluch-Oles J, Koziol-Montewka M, Magrys A. 2009. Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis isolates from Eastern Poland. New Microbiol. 32:147-152.
39. Pan XS, Fisher LM. 1997. Targeting of DNA gyrase in Streptococcus pneumoniae by sparfloxacin: selective targeting of gyrase or topoisomerase IV by quinolones. Antimicrob Agents Chemother. 41:471-474.
40. Park S, et al. 2011. Alterations of gyrA, gyrB, and parC and activity of efflux pump in fluoroquinolone-resistant Acinetobacter baumannii. Osong Public Health Res Perspect. 2:164-170.
41. Paulander W, Maisnier-Patin S, Andersson DI. 2009. The fitness cost of streptomycin resistance depends on rpsl mutation, carbon source and RpoS (sigma(s)). Genetics 183:539-546.
42. Qi Q, Preston GM, MacLean RC. 2014. Linking system-wide impacts of RNA polymerase mutations to the fitness cost of rifampin resistance in Pseudomonas aeruginosa. MBio 5:e01562.
43. Qiu XH, Yan X, Liu MX, Han RC. 2012. Genetic and proteomic characterization of rpob mutations and their effect on nematicidal activity in Photorhabdus luminescens LN2. PLoS One 7:e43114.
44. R Core Team. 2014. R: a language and environment for statistical computing [internet]. Vienna (Austria): R Foundation for Statistical Computing. Available from: http://www.R-project.org.
45. Ricci V, Peterson ML, Rotschafer JC, Wexler H, Piddock LJ. 2004. Role of topoisomerase mutations and efflux in fluoroquinolone resistance of Bacteroides fragilis clinical isolates and laboratory mutants. Antimicrob Agents Chemother. 48:1344-1346.
46. Saenz Y, Zarazaga M, Brinas L, Ruiz-Larrea F, Torres C. 2003. Mutations in gyrA and parC genes in nalidixic acid-resistant Escherichia coli strains from food products, humans and animals. J Antimicrob Chemother. 51:1001-1005.
47. Schmieder R, Edwards R. 2012. Insights into antibiotic resistance through metagenomic approaches. Future Microbiol. 7:73-89.
48. Shen LL, et al. 1989. Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug - DNA binding model. Biochemistry 28:3886-3894.
49. Silva RF, et al. 2011. Pervasive sign epistasis between conjugative plasmids and drug-resistance chromosomal mutations. PLoS Genet. 7: e1002181.
50. Siu GK, et al. 2011. Mutations outside the rifampicin resistance-determining region associated with rifampicin resistance in Mycobacterium tuberculosis. J Antimicrob Chemother. 66:730-733.
51. Taniguchi H, et al. 1996. Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis. FEMS Microbiol Lett. 144:103-108.
52. Toivonen JM, Boocock MR, Jacobs HT. 1999. Modelling in Escherichia coli of mutations in mitoribosomal protein S12: novel mutant phenotypes of rpsL. Mol Microbiol. 31:1735-1746.
53. Vallés Y, et al. 2014. Microbial succession in the gut: directional trends of taxonomic and functional change in a birth cohort of Spanish infants. PLoS Genet. 10:e1004406.
54. Wang FF, et al. 2011. High-resolution melting facilitates mutation screening of rpsL gene associated with streptomycin resistance in Mycobacterium tuberculosis. Microbiol Res. 166:121-128.
55. Watanabe Y, Cui L, Katayama Y, Kozue K, Hiramatsu K. 2011. Impact of rpoB mutations on reduced vancomycin susceptibility in Staphylococcus aureus. J Clin Microbiol. 49:2680-2684.
56. Williams DL, et al. 1998. Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 42:1853-1857.
57. Wrande M, Roth JR, Hughes D. 2008. Accumulation of mutants in "aging" bacterial colonies is due to growth under selection, not stress-induced mutagenesis. Proc Natl Acad Sci U S A. 105:11863-11868.
58. Yoshida H, Bogaki M, Nakamura M, Nakamura S. 1990. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob Agents Chemother. 34:1271-1272.